The spatial distribution of districtwide dengue cases and dengue incidence rate (DIR) per million in Bangladesh in 2019–2023. by Kamal Hossain (331680)

Subjects:

Monthly distribution of dengue cases across Bangladesh in 2022–2023. by Kamal Hossain (331680)

Subjects:

The spatial pattern of dengue including hotspot and coldspot in Bangladesh in 2019–2023. by Kamal Hossain (331680)

Subjects:

The spatial distribution of dengue incidence rate per million by month across districts of Bangladesh in 2023. by Kamal Hossain (331680)

Subjects:

The spatial (districtwide) distribution of census population of Bangladesh in 2022. by Kamal Hossain (331680)

Subjects:

The spatial distribution of dengue incidence rate per million by month across districts of Bangladesh in 2022. by Kamal Hossain (331680)

Subjects:

Global Spatial Autocorrelation Analysis of dengue log incidence rate (DLIR) with higher order neighbor districts in the study periods. by Kamal Hossain (331680)

Subjects:

Flowchart of Methodology. by Kamal Hossain (331680)

Subjects:

Network of the downregulated proteins present in _sEVs-IC and the miRs from WL-IC that might regulate them. by María-Angélica Calderón-Peláez (2851865)

GO analysis of the found proteins. by María-Angélica Calderón-Peláez (2851865)

“…During infectious diseases, EVs can also carry viral molecules that may contribute to viral spread, as previously reported for dengue virus (DENV). EVs from infected endothelial cells (EC) may harbor viral segments and various sets of molecules that could contribute to endothelial dysfunction during severe dengue. …”

List of miRs found in _sEVs-NIC and _sEVs-IC. by María-Angélica Calderón-Peláez (2851865)

“…During infectious diseases, EVs can also carry viral molecules that may contribute to viral spread, as previously reported for dengue virus (DENV). EVs from infected endothelial cells (EC) may harbor viral segments and various sets of molecules that could contribute to endothelial dysfunction during severe dengue. …”

List of proteins found in _sEVs-NIC and _sEVs-IC. by María-Angélica Calderón-Peláez (2851865)

“…During infectious diseases, EVs can also carry viral molecules that may contribute to viral spread, as previously reported for dengue virus (DENV). EVs from infected endothelial cells (EC) may harbor viral segments and various sets of molecules that could contribute to endothelial dysfunction during severe dengue. …”

Proteomic analysis of _sEVs. by María-Angélica Calderón-Peláez (2851865)

Supplemental glucose in high glucose DMEM is not required for Aag2 cell proliferation, viability, or DENV shedding or infectivity. by Andrew D. Marten (14002805)

Effects of vitamin D on the time course of DENV-2 infection in human primary macrophages. by Yordi Sebastián Tamayo-Molina (22103795)

List of antibodies used in this study. by Riya Ghosh (17116962)

“…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”

List of primers used in this study. by Riya Ghosh (17116962)

“…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”

Striking image. by Riya Ghosh (17116962)

“…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”

Study subjects. by Riya Ghosh (17116962)

“…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”

List of reagents used in this study. by Riya Ghosh (17116962)

“…CAY10585, a HIF1α-inhibitor, decreased the DENV2 infection by increasing <i>IFN-A/B</i> and <i>IRF-3/7/9</i> expression. …”